Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eosinophilic Airway Inflammation: Relationship to Remodeling and Modulation by Mepolizumab

NCT00802438 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT00802438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00802438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eosinophilic Airway Inflammation: Relationship to Remodeling and Modulation by Mepolizumab
Lead sponsor
University of Wisconsin, Madison
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2008
Completion date
March 1, 2013
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma